Scientific paper - Letter
The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study
Psychiatry Research, 279 (2019); 389-390. https://doi.org/10.1016/j.psychres.2019.04.028


Cite this document

Živković, M., Mihaljević Peleš, A., Muck Šeler, D., Šagud, M., Ganoci, L., Vlatković, S. ... Pivac, N. (2019). The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study. Psychiatry Research, 279., 389-390. doi: 10.1016/j.psychres.2019.04.028

Živković, Maja, et al. "The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study." Psychiatry Research, vol. 279, 2019, pp. 389-390. https://doi.org/10.1016/j.psychres.2019.04.028

Živković, Maja, Alma Mihaljević Peleš, Dorotea Muck Šeler, Marina Šagud, Lana Ganoci, Suzana Vlatković, Matea Nikolac Perković, Lucija Tudor, Nada Božina and Nela Pivac. "The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study." Psychiatry Research 279 (2019): 389-390. https://doi.org/10.1016/j.psychres.2019.04.028

Živković, M., et al. (2019) 'The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study', Psychiatry Research, 279, pp. 389-390. doi: 10.1016/j.psychres.2019.04.028

Živković M, Mihaljević Peleš A, Muck Šeler D, Šagud M, Ganoci L, Vlatković S, and sur.. The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study. Psychiatry Research [Internet]. 2019 September [cited 2022 January 17];279:389-390. doi: 10.1016/j.psychres.2019.04.028

M. Živković, et al., "The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study", Psychiatry Research, vol. 279, pp. 389-390, September 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:203373. [Accessed: 17 January 2022]

Please login to the repository to save this object to your list.